July 12, 2017 10:35 AM EDTUpdated July 12, 11:26 PM

Erytech collaborates on rare disease drug; Enterome creates diagnostics venture with Nestlé

Shehla Shakoor

Managing Director

⟶ France’s Erytech has forged a collaboration with Queen’s University in Canada on their eryminase program specifically for the treatment of arginase-1 deficiency, a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Erytech collaborates on rare disease drug; Enterome creates diagnostics venture with Nestlé

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Updated: Trump administration reveals 'most favored nation' drug price country targets

In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines

Updated: FDA adcomm splits votes on Genentech and J&J cancer drugs

Makary, Prasad spell out FDA ground rules for future Covid vaccine approvals

RFK Jr. spars with senators over research cuts, HHS budget plan

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?

Ery­tech col­lab­o­rates on rare dis­ease drug; En­terome cre­ates di­ag­nos­tics ven­ture with Nestlé

Shehla Shakoor

Managing Director

Sign up to read this article for free.

Up­dat­ed: Trump ad­min­is­tra­tion re­veals 'most fa­vored na­tion' drug price coun­try tar­gets

In his first ma­jor pol­i­cy roll­out, Vinay Prasad looks to chal­lenge ex­ist­ing 'dog­ma' on Covid vac­cines

Up­dat­ed: FDA ad­comm splits votes on Genen­tech and J&J can­cer drugs

Makary, Prasad spell out FDA ground rules for fu­ture Covid vac­cine ap­provals

RFK Jr. spars with sen­a­tors over re­search cuts, HHS bud­get plan

Does your sup­ply chain hold up un­der pres­sure for high-risk tem­per­a­ture-crit­i­cal ship­ments?

Erytech collaborates on rare disease drug; Enterome creates diagnostics venture with Nestlé

Updated: Trump administration reveals 'most favored nation' drug price country targets

In his first major policy rollout, Vinay Prasad looks to challenge existing 'dogma' on Covid vaccines

Updated: FDA adcomm splits votes on Genentech and J&J cancer drugs

Makary, Prasad spell out FDA ground rules for future Covid vaccine approvals

RFK Jr. spars with senators over research cuts, HHS budget plan

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?